{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+equivalent&page=13", "query": { "intervention": "Placebo equivalent", "page": 13 }, "page_size": 10 }, "pagination": { "page": 13, "page_size": 10, "total_count": 843, "total_pages": 85, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+equivalent&page=14&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+equivalent&page=12&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-13T02:56:51.314Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01896531", "title": "A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gastric Cancer" ], "interventions": [ { "name": "5-Fluorouracil", "type": "DRUG" }, { "name": "Ipatasertib", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 153, "start_date": "2013-08-14", "completion_date": "2021-01-26", "has_results": true, "last_update_posted_date": "2022-03-02", "last_synced_at": "2026-11-13T02:56:51.314Z", "location_count": 3, "location_summary": "Los Angeles, California • Boston, Massachusetts • Houston, Texas", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01896531" }, { "nct_id": "NCT06873945", "title": "A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alopecia Areata" ], "interventions": [ { "name": "Ritlecitinib 100 mg", "type": "DRUG" }, { "name": "Ritlecitinib 50 mg", "type": "DRUG" }, { "name": "Placebo - 100 mg", "type": "DRUG" }, { "name": "Placebo - 50 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 674, "start_date": "2025-04-01", "completion_date": "2028-03-19", "has_results": false, "last_update_posted_date": "2026-10-20", "last_synced_at": "2026-11-13T02:56:51.314Z", "location_count": 60, "location_summary": "Birmingham, Alabama • Hot Springs, Arkansas • Brea, California + 39 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Brea", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06873945" }, { "nct_id": "NCT03914495", "title": "The Role of Microbiome Reprogramming on Liver Fat Accumulation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "NAFLD" ], "interventions": [ { "name": "Inulin", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "AdventHealth Translational Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "35 Years to 65 Years" }, "enrollment_count": 57, "start_date": "2019-05-21", "completion_date": "2021-06-09", "has_results": false, "last_update_posted_date": "2023-02-13", "last_synced_at": "2026-11-13T02:56:51.314Z", "location_count": 1, "location_summary": "Orlando, Florida", "locations": [ { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03914495" }, { "nct_id": "NCT00377637", "title": "A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lupus Nephritis" ], "interventions": [ { "name": "Mycophenolate mofetil (MMF)", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Azathioprine", "type": "DRUG" }, { "name": "Placebo to Azathioprine", "type": "DRUG" }, { "name": "Placebo to Mycophenolate mofetil", "type": "DRUG" }, { "name": "Corticosteroid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 370, "start_date": "2005-07", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2011-12-06", "last_synced_at": "2026-11-13T02:56:51.314Z", "location_count": 28, "location_summary": "Huntsville, Alabama • La Jolla, California • Los Angeles, California + 22 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Leandro", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00377637" }, { "nct_id": "NCT00198822", "title": "Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Vitamin A Deficiency", "Maternal Mortality", "Infant Mortality" ], "interventions": [ { "name": "Vitamin A or Beta-Carotene Supplements", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "15 Years", "maximum_age": "49 Years", "sex": "FEMALE", "summary": "15 Years to 49 Years · Female only" }, "enrollment_count": 59666, "start_date": "2001-08", "completion_date": "2008-03", "has_results": true, "last_update_posted_date": "2012-03-07", "last_synced_at": "2026-11-13T02:56:51.314Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00198822" }, { "nct_id": "NCT02040766", "title": "A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Beclomethasone dipropionate BAI", "type": "DRUG" }, { "name": "Placebo BAI", "type": "DRUG" }, { "name": "albuterol/salbutamol 90 mcg", "type": "DRUG" }, { "name": "Beclomethasone dipropionate MDI", "type": "DRUG" }, { "name": "Placebo MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 628, "start_date": "2013-12", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-11-13T02:56:51.314Z", "location_count": 75, "location_summary": "Hoover, Alabama • Montgomery, Alabama • Phoenix, Arizona + 62 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02040766" }, { "nct_id": "NCT05379634", "title": "A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myositis" ], "interventions": [ { "name": "Nipocalimab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Glucocorticoids", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2022-07-05", "completion_date": "2026-09-17", "has_results": false, "last_update_posted_date": "2026-11-04", "last_synced_at": "2026-11-13T02:56:51.314Z", "location_count": 19, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Beverly Hills, California + 15 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05379634" }, { "nct_id": "NCT04018300", "title": "Iron Supplementation and Side Effects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Iron Deficiency Anemia", "Iron Overload" ], "interventions": [ { "name": "Ferrous sulfate", "type": "DIETARY_SUPPLEMENT" }, { "name": "Aspiron", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Iowa State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "FEMALE", "summary": "18 Years to 40 Years · Female only" }, "enrollment_count": 17, "start_date": "2018-01-08", "completion_date": "2018-04-18", "has_results": false, "last_update_posted_date": "2019-07-12", "last_synced_at": "2026-11-13T02:56:51.314Z", "location_count": 1, "location_summary": "Ames, Iowa", "locations": [ { "city": "Ames", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT04018300" }, { "nct_id": "NCT02499120", "title": "Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Squamous Cell Carcinoma of the Head and Neck (SCCHN)" ], "interventions": [ { "name": "palbociclib", "type": "DRUG" }, { "name": "Cetuximab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2015-09-10", "completion_date": "2022-09-07", "has_results": true, "last_update_posted_date": "2023-09-08", "last_synced_at": "2026-11-13T02:56:51.314Z", "location_count": 14, "location_summary": "La Jolla, California • San Diego, California • Louisville, Kentucky + 7 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02499120" }, { "nct_id": "NCT01599286", "title": "Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Propionic Acidemia, Type I and/or Type II", "Methylmalonic Acidemia", "Carbamoyl-Phosphate Synthase I Deficiency Disease", "Ornithine Carbamoyltransferase Deficiency" ], "interventions": [ { "name": "Carbaglu", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mendel Tuchman", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Week", "maximum_age": "99 Years", "sex": "ALL", "summary": "1 Week to 99 Years" }, "enrollment_count": 35, "start_date": "2012-09-01", "completion_date": "2020-04-30", "has_results": true, "last_update_posted_date": "2021-02-15", "last_synced_at": "2026-11-13T02:56:51.314Z", "location_count": 9, "location_summary": "Los Angeles, California • Palo Alto, California • Aurora, Colorado + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01599286" } ] }